Evidence map›Paper›PMID 41484880›Full record

ArticleBMC complementary medicine and therapies2026

Oral fermented rice bran supplementation suppresses viral replication and stimulates immune functions in immunocompetent and immunocompromised mice infected with influenza virus.

Kyoko Hayashi, Satomi Asai, Yoshiteru Maehara, Jung-Bum Lee, Masako Hinatsu, Taizo Watanabe, Kazuo Maehara, Toshio Kawahara

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kyoko HayashiCollege of Life and Health Sciences, Chubu University, Kasugai, Aichi, 487- 8501, Japan.
Satomi AsaiDepartment of Laboratory Medicine, School of Medicine, Tokai University, Isehara, Kanagawa, 259-1193, Japan.
Yoshiteru MaeharaMAXPROBIO Co. Ltd, Omihachiman, Shiga, 523-0881, Japan.
Jung-Bum LeeFaculty of Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama, Toyama, 2630, 930-0194, Japan.
Masako HinatsuGraduate School of Engineering, Chubu University, Kasugai, Aichi, 487- 8501, Japan.
Taizo WatanabeMAXPROBIO Co. Ltd, Omihachiman, Shiga, 523-0881, Japan.
Kazuo MaeharaMAXPROBIO Co. Ltd, Omihachiman, Shiga, 523-0881, Japan.
Toshio KawaharaCollege of Life and Health Sciences, Chubu University, Kasugai, Aichi, 487- 8501, Japan. toshi@isc.chubu.ac.jp.

Funding

Japan Society for the Promotion of Science 22K04902JST-Mirai Program JPMJMI22D2
6 · The paper itself

Abstract

backgroundThe number of immunosuppressed elderly persons, who are at a higher risk of developing influenza infection-related complications, has been increasing. Fermented rice bran (FRB) is used as a dietary supplement, exhibits a variety of biological activities, and may exhibit anti-influenza virus activity. However, the effect of FRB supplements on influenza A virus (IFV) infection remains unknown. We aimed to investigate the effects of FRB on influenza prevention by oral administration to IFV-infected mice in an immunocompetent or immunocompromised state.

methodsFRB was produced by fermentation of rice bran with a mixture of Bacillus spp, Lactobacillus sp, Bifidobacterium sp, and Aspergillus sp. BALB/c mice orally received FRB (20 mg/day) for 1 or 2 months prior to intranasal IFV inoculation or immediately after IFV infection until 14 days post-inoculation. Weight changes, virus production, levels of neutralizing antibodies, immunoglobulin A (IgA) and interferon-γ (IFN-γ), and histological changes of the intestine were analyzed in FRB-administered mice.

resultsFRB-administered immunocompetent mice without 5-fluorouracil (5-FU) treatment showed suppressed body weight loss caused by IFV-infection and rapid weight recovery. The virus yields in the lungs of FRB groups were reduced 3 days post-infection. Neutralizing antibody titers in the blood and respiratory tract and IgA levels in the lung and intestine were increased in FRB groups after 14 days of infection. An elevation in IFN-γ levels was observed in the blood of FRB-treated mice on days 3 and 14 after virus inoculation. In immunocompromised mice treated with 5-FU, oral FRB administration beginning 1 month prior to IFV inoculation resulted in significant suppression of body weight loss, reduced viral titers in the lung, elevated systemic and local neutralizing antibody titers, and preservation of normal colonic morphology compared with the control group. In contrast, when FRB was administered 1 h after viral inoculation, these protective effects were present but notably less pronounced than those observed with supplementation pre-inoculation.

conclusionsFRB stimulates local and systemic adaptive immune functions, favors early recovery from influenza, and prolongs protective effects against IFV infection in both immunocompetent and immunocompromised mice.

Indexed as

Dietary SupplementsInfluenza A virusOrthomyxoviridae InfectionsOryzaVirus ReplicationAdministration, OralAnimalsFemaleFermentationImmunocompromised HostMiceMice, Inbred BALB CFermented rice branImmunocompetent miceImmunocompromised miceNeutralizing antibodyProtective effectsSecretory IgA levelsVirus yields

Identifiers

PMID41484880
PMCPMC12866010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.